UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 766

Sortiert nach

Circulating microRNAs as potential new biomarkers for prostate cancer

British journal of cancer, 2013-05, Vol.108 (10), p.1925-1935

2013

Volltextzugriff (PDF)

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells

Nature communications, 2021-07, Vol.12 (1), p.4068-4068, Article 4068

2021

Volltextzugriff (PDF)

Revising the role of the androgen receptor in breast cancer

Journal of molecular endocrinology, 2014-06, Vol.52 (3), p.R257-R265

2014

Volltextzugriff (PDF)

Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression

Oncogene, 2008-05, Vol.27 (21), p.2941-2950

2008

Volltextzugriff (PDF)

HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions

Oncogene, 2010-01, Vol.29 (3), p.411-420

2010

Volltextzugriff (PDF)

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity

Oncogene, 2007-03, Vol.26 (12), p.1757-1768

2007

Volltextzugriff (PDF)

The Role of Androgen Receptor Mutations in Prostate Cancer Progression

Current genomics, 2009-03, Vol.10 (1), p.18-25

2009

Volltextzugriff (PDF)

Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer

Journal of endocrinology, 2023-03, Vol.256 (3)

2023

Volltextzugriff (PDF)

High fat diet causes distinct aberrations in the testicular proteome

International Journal of Obesity, 2020-09, Vol.44 (9), p.1958-1969

2020

Volltextzugriff (PDF)

Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate

Endocrine-related cancer, 2004-03, Vol.11 (1), p.117-130

2004

Volltextzugriff (PDF)

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer

Molecular cancer, 2022-03, Vol.21 (1), p.82-22, Article 82

2022

Volltextzugriff (PDF)

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens

Oncogene, 2012-10, Vol.31 (43), p.4588-4598

2012

Volltextzugriff (PDF)

The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells

Oncogenesis (New York, NY), 2017-05, Vol.6 (5), p.e333-e333

2017

Volltextzugriff (PDF)

Notch signaling: a potential therapeutic target in prostate cancer

Current cancer drug targets, 2008-11, Vol.8 (7), p.566

2008

Volltextzugriff (PDF)

The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1

Molecular and Cellular Biology, 1999-12, Vol.19 (12), p.8383-8392

1999

Volltextzugriff (PDF)

Phenotypic diversity in siblings with partial androgen insensitivity syndrome

Archives of disease in childhood, 1997-06, Vol.76 (6), p.529-531

1997

Volltextzugriff (PDF)

Functional Analysis of Six Androgen Receptor Mutations Identified in Patients with Partial Androgen Insensitivity Syndrome

Human molecular genetics, 1996-02, Vol.5 (2), p.265-273

1996

Volltextzugriff (PDF)

Mechanisms of androgen receptor repression in prostate cancer

Biochemical Society transactions, 2006-12, Vol.34 (Pt 6), p.1124

2006

Volltextzugriff (PDF)

Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers

Endocrine-related cancer, 2014-10, Vol.21 (5), p.R409-R429

2014

Volltextzugriff (PDF)

Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome

The Journal of steroid biochemistry and molecular biology, 1997-04, Vol.61 (1), p.19-26

1997

Volltextzugriff (PDF)

Hey1, a Mediator of Notch Signaling, Is an Androgen Receptor Corepressor

Molecular and Cellular Biology, 2005-02, Vol.25 (4), p.1425-1436

2005

Volltextzugriff (PDF)

Androgens target prohibitin to regulate proliferation of prostate cancer cells

Oncogene, 2004-04, Vol.23 (17), p.2996-3004

2004

Volltextzugriff (PDF)

P5-06-06: The RNA Binding Protein FUS Is a Potential Marker for Breast Cancer Progression and Therapy Response

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P5-P5-06-06

2011

Volltextzugriff (PDF)

Characterization of the Two Coactivator-interacting Surfaces of the Androgen Receptor and Their Relative Role in Transcriptional Control

The Journal of biological chemistry, 2002-12, Vol.277 (51), p.49230-49237

2002

Volltextzugriff (PDF)

Androgen receptor in prostate cancer: cause or cure?

Trends in endocrinology and metabolism, 2005-11, Vol.16 (9), p.395-397

Bevan, Charlotte L.

2005

Volltextzugriff (PDF)

1 – 25 von 766

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(687)
Mit Volltextzugriff
(682)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(447)
Life Sciences & Biomedicine
(301)
Humans
(248)
Male
(167)
Female
(142)
Biological And Medical Sciences
(140)
Physics
(107)
Medical Sciences
(106)
Physical Sciences
(104)
Adult
(103)
Middle Aged
(94)
Animals
(75)
Aged
(65)
Technology
(58)
Fundamental And Applied Biological Sciences. Psychology
(50)
Neurosciences & Neurology
(39)
Physics, Particles & Fields
(38)
Adolescent
(36)
Clinical Neurology
(35)
Biochemistry & Molecular Biology
(34)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Circulating microRNAs as potential new biomarkers for prostate cancer

The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells

Revising the role of the androgen receptor in breast cancer

Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression

HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions

Prohibitin, a protein downregulated by androgens, represses androgen receptor activity

The Role of Androgen Receptor Mutations in Prostate Cancer Progression

Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer

High fat diet causes distinct aberrations in the testicular proteome

Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate

A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer

Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens

The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells

Notch signaling: a potential therapeutic target in prostate cancer

The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1

Phenotypic diversity in siblings with partial androgen insensitivity syndrome

Functional Analysis of Six Androgen Receptor Mutations Identified in Patients with Partial Androgen Insensitivity Syndrome

Mechanisms of androgen receptor repression in prostate cancer

Interplay between steroid signalling and microRNAs: implications for hormone-dependent cancers

Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome

Hey1, a Mediator of Notch Signaling, Is an Androgen Receptor Corepressor

Androgens target prohibitin to regulate proliferation of prostate cancer cells

P5-06-06: The RNA Binding Protein FUS Is a Potential Marker for Breast Cancer Progression and Therapy Response

Characterization of the Two Coactivator-interacting Surfaces of the Androgen Receptor and Their Relative Role in Transcriptional Control

Androgen receptor in prostate cancer: cause or cure?

Suchergebnisse filtern